Baidu
map

Diabetes Care:室颤复苏后血糖急增者预后差

2012-02-04 MedSci MedSci原创

  来自芬兰一项基于人群的观察性研究证实,对于接受院外心室颤动复苏的患者,其不良转归或可通过复苏后超急性期血糖水平显著升高来预测。研究在2012年1月25日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究旨在评价医院外室颤复苏成功后即刻的血糖变化趋势。研究共纳入了2005至2009年间170名经历复苏后入院存活的成年患者,这些患者均为旁观者目击的心源性心搏骤停并以心室颤动

  来自芬兰一项基于人群的观察性研究证实,对于接受院外心室颤动复苏的患者,其不良转归或可通过复苏后超急性期血糖水平显著升高来预测。研究在2012年1月25日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  该研究旨在评价医院外室颤复苏成功后即刻的血糖变化趋势。研究共纳入了2005至2009年间170名经历复苏后入院存活的成年患者,这些患者均为旁观者目击的心源性心搏骤停并以心室颤动为初始节律。研究者对这些受试者的心搏骤停记录和血糖数据进行了分析。

  结果显示,共有134例(79%)受试者的数据资料充足,其中有87人(65%,95%可信区间为57-73%)在出院后生存,其脑功能分类为1或2。生存人群在入院前(10.5±4.1 mmol / L)和住院过程中(10.0±3.7 mmol / L)的血糖水平没有显著性变化(P=0.3483);但死亡人群的血糖水平从(11.8±4.6)mmol/L升高至(13.8±3.3)mmol/L(P = 0.0025)。

  链接:

  Early Increase in Blood Glucose in Patients Resuscitated From Out-of-Hospital Ventricular Fibrillation Predicts Poor Outcome

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1636469, encodeId=64aa1636469c8, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 21 00:04:00 CST 2012, time=2012-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759109, encodeId=7acb1e5910946, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Mar 17 02:04:00 CST 2012, time=2012-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900921, encodeId=0a19190092113, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Aug 14 09:04:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305331, encodeId=0eaf130533182, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332243, encodeId=ffd01332243a3, content=<a href='/topic/show?id=af2646250e1' target=_blank style='color:#2F92EE;'>#室颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46250, encryptionId=af2646250e1, topicName=室颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1636469, encodeId=64aa1636469c8, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 21 00:04:00 CST 2012, time=2012-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759109, encodeId=7acb1e5910946, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Mar 17 02:04:00 CST 2012, time=2012-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900921, encodeId=0a19190092113, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Aug 14 09:04:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305331, encodeId=0eaf130533182, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332243, encodeId=ffd01332243a3, content=<a href='/topic/show?id=af2646250e1' target=_blank style='color:#2F92EE;'>#室颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46250, encryptionId=af2646250e1, topicName=室颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1636469, encodeId=64aa1636469c8, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 21 00:04:00 CST 2012, time=2012-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759109, encodeId=7acb1e5910946, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Mar 17 02:04:00 CST 2012, time=2012-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900921, encodeId=0a19190092113, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Aug 14 09:04:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305331, encodeId=0eaf130533182, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332243, encodeId=ffd01332243a3, content=<a href='/topic/show?id=af2646250e1' target=_blank style='color:#2F92EE;'>#室颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46250, encryptionId=af2646250e1, topicName=室颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1636469, encodeId=64aa1636469c8, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 21 00:04:00 CST 2012, time=2012-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759109, encodeId=7acb1e5910946, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Mar 17 02:04:00 CST 2012, time=2012-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900921, encodeId=0a19190092113, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Aug 14 09:04:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305331, encodeId=0eaf130533182, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332243, encodeId=ffd01332243a3, content=<a href='/topic/show?id=af2646250e1' target=_blank style='color:#2F92EE;'>#室颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46250, encryptionId=af2646250e1, topicName=室颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
    2012-02-05 lizhou0204
  5. [GetPortalCommentsPageByObjectIdResponse(id=1636469, encodeId=64aa1636469c8, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Thu Jun 21 00:04:00 CST 2012, time=2012-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759109, encodeId=7acb1e5910946, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Sat Mar 17 02:04:00 CST 2012, time=2012-03-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900921, encodeId=0a19190092113, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Tue Aug 14 09:04:00 CST 2012, time=2012-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1305331, encodeId=0eaf130533182, content=<a href='/topic/show?id=270342e249d' target=_blank style='color:#2F92EE;'>#复苏#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42724, encryptionId=270342e249d, topicName=复苏)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d01326, createdName=lizhou0204, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1332243, encodeId=ffd01332243a3, content=<a href='/topic/show?id=af2646250e1' target=_blank style='color:#2F92EE;'>#室颤#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=46250, encryptionId=af2646250e1, topicName=室颤)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=101c2500074, createdName=124987e8m07暂无昵称, createdTime=Sun Feb 05 16:04:00 CST 2012, time=2012-02-05, status=1, ipAttribution=)]
Baidu
map
Baidu
map
Baidu
map